Physiology and diagnostic potential of beta-hydroxybutyrate in neonatal glycemia – a prospective cohort study
Clicks: 4
ID: 322687
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
4 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #67 of 359 articles by views in the journal of clinical endocrinology & metabolism
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 359 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
CONTEXT: Neonatal hypoglycemia is the most common metabolic disorder in newborns and may lead to adverse neurodevelopment. The role of alternative substrates such as beta-hydroxybutyrate (BOHB) during neonatal hypoglycemia is poorly understood. OBJECTIVE: To examine BOHB in neonates with and without hypoglycemia risk factors across different feeding regimens, and to estimate the potential to guide discontinuation of blood glucose (BG) screening. DESIGN: Prospective cohort study (05/2020-09/2022). Standardized BG and BOHB measurements. SETTING: Single-center tertiary hospital. PARTICIPANTS: 895 neonates with (n = 752) and without (n = 143, controls) hypoglycemia risk factors. INTERVENTION: None. MAIN OUTCOMES MEASURES: Comparison of BG and combined BG + BOHB values and percentiles across different risk factors and feeding regimens. Ketonemia was defined as BOHB >0.5 mmol/L. RESULTS: Of 516 neonates with BOHB measurements at ≥24 hours of age, 107 (20.7%) had ketonemia. Ketonemia was more frequent in controls than in at-risk neonates (28.2% (33/117) vs. 18.6% (74/399), P = .023), and in neonates receiving exclusively breastmilk than in exclusively formula-fed neonates (34% (16/47) vs. 3% (1/39), P < .001). BG and BG + BOHB percentile trajectories diverged more over time in controls, large-for-gestational-age neonates, and infants of diabetic mothers than in small-for-gestational and/or fetal-growth-restricted, preterm, or perinatally stressed neonates. CONCLUSIONS: Neonates with hypoglycemia risk factors and those receiving formula developed less ketonemia. The low overall incidence of ketonemia and its dependence on feeding regimen - particularly among at-risk neonates - limit the utility of BOHB, alone or in combination with BG, as a broadly applicable marker for determining when hypoglycemia screening can be safely discontinued.
| Reference Key |
openalex_W7171381299
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Henrike Hoermann, Ertan Mayatepek, Thomas Meissner, Marcia Roeper, Sebastian Kummer |
| Journal | the journal of clinical endocrinology & metabolism |
| Year | 2026 |
| DOI |
10.1210/clinem/dgag300
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.